
### [MONDO:0002977](http://purl.obolibrary.org/obo/MONDO_0002977)
**Label:** autoimmune disease of the nervous system

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0013673](http://purl.obolibrary.org/obo/MONDO_0013673) (Wolfram-like syndrome), [MONDO:0013893](http://purl.obolibrary.org/obo/MONDO_0013893) (multiple sclerosis, susceptibility to, 5), [MONDO:0018105](http://purl.obolibrary.org/obo/MONDO_0018105) (Wolfram syndrome), [MONDO:0018325](http://purl.obolibrary.org/obo/MONDO_0018325) (juvenile myasthenia gravis), [MONDO:0018326](http://purl.obolibrary.org/obo/MONDO_0018326) (transient neonatal myasthenia gravis), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0018324](http://purl.obolibrary.org/obo/MONDO_0018324) (adult-onset myasthenia gravis), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0018092](http://purl.obolibrary.org/obo/MONDO_0018092) (Vogt-Koyanagi-Harada disease), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0011776](http://purl.obolibrary.org/obo/MONDO_0011776) (CINCA syndrome), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0007462](http://purl.obolibrary.org/obo/MONDO_0007462) (multiple sclerosis, susceptibility to), [MONDO:0010800](http://purl.obolibrary.org/obo/MONDO_0010800) (Wolfram syndrome, mitochondrial form), [MONDO:0018826](http://purl.obolibrary.org/obo/MONDO_0018826) (Lewis-Sumner syndrome), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0009101](http://purl.obolibrary.org/obo/MONDO_0009101) (Wolfram syndrome 1), [MONDO:0019100](http://purl.obolibrary.org/obo/MONDO_0019100) (neuromyelitis optica), [MONDO:0008036](http://purl.obolibrary.org/obo/MONDO_0008036) (myasthenia, limb-girdle, autoimmune), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0012958](http://purl.obolibrary.org/obo/MONDO_0012958) (MS4), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0007691](http://purl.obolibrary.org/obo/MONDO_0007691) (Guillain-Barre syndrome), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0012957](http://purl.obolibrary.org/obo/MONDO_0012957) (MS3), [MONDO:0012956](http://purl.obolibrary.org/obo/MONDO_0012956) (MS2), [MONDO:0011768](http://purl.obolibrary.org/obo/MONDO_0011768) (myasthenia gravis with thymus hyperplasia), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0011502](http://purl.obolibrary.org/obo/MONDO_0011502) (Wolfram syndrome 2), 

**Corr. equiv. classes:** [Orphanet:48162](http://www.orpha.net/ORDO/Orphanet_48162), [OMIM:159400](http://purl.obolibrary.org/obo/OMIM_159400), [OMIM:607115](http://purl.obolibrary.org/obo/OMIM_607115), [OMIM:306400](http://purl.obolibrary.org/obo/OMIM_306400), [OMIM:222300](http://purl.obolibrary.org/obo/OMIM_222300), [Orphanet:391497](http://www.orpha.net/ORDO/Orphanet_391497), [Orphanet:85408](http://www.orpha.net/ORDO/Orphanet_85408), [OMIM:604928](http://purl.obolibrary.org/obo/OMIM_604928), [Orphanet:391490](http://www.orpha.net/ORDO/Orphanet_391490), [OMIM:614296](http://purl.obolibrary.org/obo/OMIM_614296), [Orphanet:411590](http://www.orpha.net/ORDO/Orphanet_411590), [OMIM:612594](http://purl.obolibrary.org/obo/OMIM_612594), [Orphanet:3437](http://www.orpha.net/ORDO/Orphanet_3437), [OMIM:612596](http://purl.obolibrary.org/obo/OMIM_612596), [Orphanet:247854](http://www.orpha.net/ORDO/Orphanet_247854), [OMIM:613960](http://purl.obolibrary.org/obo/OMIM_613960), [OMIM:612595](http://purl.obolibrary.org/obo/OMIM_612595), [Orphanet:1451](http://www.orpha.net/ORDO/Orphanet_1451), [OMIM:614810](http://purl.obolibrary.org/obo/OMIM_614810), [OMIM:139393](http://purl.obolibrary.org/obo/OMIM_139393), [OMIM:233700](http://purl.obolibrary.org/obo/OMIM_233700), [Orphanet:71211](http://www.orpha.net/ORDO/Orphanet_71211), [OMIM:598500](http://purl.obolibrary.org/obo/OMIM_598500), [Orphanet:247839](http://www.orpha.net/ORDO/Orphanet_247839), [Orphanet:481662](http://www.orpha.net/ORDO/Orphanet_481662), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [OMIM:126200](http://purl.obolibrary.org/obo/OMIM_126200), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), [Orphanet:391504](http://www.orpha.net/ORDO/Orphanet_391504), [Orphanet:85438](http://www.orpha.net/ORDO/Orphanet_85438), [OMIM:608710](http://purl.obolibrary.org/obo/OMIM_608710), [Orphanet:90290](http://www.orpha.net/ORDO/Orphanet_90290), [OMIM:138990](http://purl.obolibrary.org/obo/OMIM_138990), [Orphanet:85410](http://www.orpha.net/ORDO/Orphanet_85410), [Orphanet:2932](http://www.orpha.net/ORDO/Orphanet_2932), [Orphanet:247861](http://www.orpha.net/ORDO/Orphanet_247861), [OMIM:233710](http://purl.obolibrary.org/obo/OMIM_233710), [Orphanet:900](http://www.orpha.net/ORDO/Orphanet_900), [OMIM:233690](http://purl.obolibrary.org/obo/OMIM_233690), [Orphanet:3463](http://www.orpha.net/ORDO/Orphanet_3463), [Orphanet:247846](http://www.orpha.net/ORDO/Orphanet_247846), [OMIM:607085](http://purl.obolibrary.org/obo/OMIM_607085), [Orphanet:589](http://www.orpha.net/ORDO/Orphanet_589), [OMIM:233670](http://purl.obolibrary.org/obo/OMIM_233670), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 36.89%
- Thing 36.87%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 36.87%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 29.11%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 27.03%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 26.00%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 23.35%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 22.65%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 22.32%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 22.11%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 20.70%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 16.57%
- [HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear) 15.97%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 15.35%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 14.70%


